Fol­low­ing an al­most year­long wait, FDA ap­proves Ax­some's rapid-act­ing de­pres­sion drug

3 years ago
Pharma
FDA+

ICY­MI: James Sabry just signed off on a land­mark first for Roche's deal­mak­ing crew

3 years ago
Bioregnum
China

Lit­tle Nor­we­gian biotech will sell it­self for parts, as it plans to ex­plore 's­trate­gic op­tion­s'

3 years ago
R&D

Strug­gling pen­ny stock biotech lays off 40% of staffers to stay afloat — for a few more weeks

3 years ago
People

Just like start­ing over: Mod­er­na tees up an­oth­er CFO; Ge­of­frey Porges puts down his SVB pen to join Schrödinger

3 years ago
Peer Review

Bay­er gets FDA nod to ex­tend use of pop­u­lar con­tra­cep­tive IUD Mire­na

3 years ago
Pharma
FDA+

Lund­beck tries to rush its FDA-ap­proved mi­graine drug to Chi­na but fails PhI­II tri­al

3 years ago
R&D
Pharma

Re­searchers call for fi­nan­cial in­cen­tives to speed con­fir­ma­to­ry tri­als for ac­cel­er­at­ed ap­provals

3 years ago
R&D

Gilead teams with CNN for poignant do­cuseries about the lives of HIV ad­vo­cates in south­ern US states 

3 years ago
Pharma
Marketing

New Jer­sey judge de­cides Bausch Health's Xi­fax­an is 'pri­or art,' does not in­fringe Cu­ria patents

3 years ago
Pharma
Law

Man­u­fac­tur­ing roundup: As­traZeneca and Sam­sung ink $350M deal; Michi­gan CD­MO com­pletes ex­pan­sion

3 years ago
Manufacturing

Cipla man­u­fac­tur­ing site in In­dia lands a Form 483 for un­clean equip­ment, lack of da­ta

3 years ago
Pharma
FDA+

Mil­lions more mon­key­pox vac­cine and an­tivi­ral cours­es com­ing to states next week, but will it be enough?

3 years ago
Pharma
FDA+

Through the lymph nodes it goes — re­searchers de­vel­op a can­cer drug that avoids tox­i­c­i­ties by skirt­ing the liv­er

3 years ago
R&D
Discovery

Al­mac com­mits to $65M ex­pan­sion for its Penn­syl­va­nia HQ amid wider in­vest­ments

3 years ago
Financing
Pharma

FDA lifts par­tial hold on Curis' lym­phoma study — shares spike

3 years ago
FDA+

Astel­las' hot flash­es drug will get speedy re­view at FDA; US opts out of Val­ne­va vac­cine

3 years ago
News Briefing

Those big bil­lion-dol­lar PhI­II stud­ies? Mar­tin Lan­dray says they can be done for a tiny frac­tion of the cost

3 years ago
R&D
In Focus

Up­dat­ed: 'Se­mi-re­tired' an­a­lyst Ge­of­frey Porges de­parts SVB to lead fi­nances at a drug dis­cov­ery shop

3 years ago
People

Roche, Genen­tech plunk down $60M up­front to part­ner with Chi­nese phar­ma on PRO­TAC-based prostate can­cer drug

3 years ago
Deals
China

Ex­sci­en­tia ter­mi­nates Bay­er pact half a year ear­ly, col­lect­ing small por­tion of €240M promised

3 years ago
Deals
AI

CSL CEO Paul Per­reault de­ter­mined to grow plas­ma col­lec­tion af­ter full-year sales dip

3 years ago
Pharma

Bay­er aims to sim­pli­fy the com­plex­i­ties of CKD with an ABC-themed ad cam­paign

3 years ago
Pharma
Marketing

En­do files for Chap­ter 11 as it looks to fin­ish off its opi­oid lit­i­ga­tion

3 years ago
Pharma
Law
First page Previous page 476477478479480481482 Next page Last page
A service from the Financial Times